Objectives: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea. Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older.Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey. Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia. Conclusion Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.

Objectives: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea. Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older.Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey. Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia. Conclusion Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.

Purpose: The purpose of this study was to develop eating traits scale for Korean adults and verify its validity and reliability. Methods: The initial items were developed based on the literature reviews. The first preliminary scale has consisted of 78 items and the second preliminary scale consisted of 50 items selected by 13 experts who were formed to evaluate the content validity. To review whether they could understand the questionnaires at their reading level, 27 sixth-grade elementary school students were asked to be involved in this study. The questionnaire was revised through the consultation of Korean language teachers, and the final preliminary scale was composed of 50 items. Data were collected from 329 adults aged 19 to 65 years to test validity and reliability of the scale The item analysis and exploratory factor analysis were applied. Results: Exploratory factor analysis showed 5 factors of 35 items. The factors (No. of items) were ‘Mood states (6)’, ‘Pursuit of health (6)’, ‘Stimulation of food (9)’, ‘Social situations (5)’, ‘Desire satisfaction (9)’. These 5 factors explained 55.04% of the total variance. Eating traits scale developed in this study was established construct validity. The reliability of the scale, Cronbach's alpha coefficient was .92 and the factor’s ranged from .77 to .87. Conclusions Eating traits scale developed in this study was verified by content validity, construct validity and reliability. It is expected to be useful measuring eating traits of Korean adults in clinical practice and research.

Purpose: The purpose of this study was to develop eating traits scale for Korean adults and verify its validity and reliability. Methods: The initial items were developed based on the literature reviews. The first preliminary scale has consisted of 78 items and the second preliminary scale consisted of 50 items selected by 13 experts who were formed to evaluate the content validity. To review whether they could understand the questionnaires at their reading level, 27 sixth-grade elementary school students were asked to be involved in this study. The questionnaire was revised through the consultation of Korean language teachers, and the final preliminary scale was composed of 50 items. Data were collected from 329 adults aged 19 to 65 years to test validity and reliability of the scale The item analysis and exploratory factor analysis were applied. Results: Exploratory factor analysis showed 5 factors of 35 items. The factors (No. of items) were ‘Mood states (6)’, ‘Pursuit of health (6)’, ‘Stimulation of food (9)’, ‘Social situations (5)’, ‘Desire satisfaction (9)’. These 5 factors explained 55.04% of the total variance. Eating traits scale developed in this study was established construct validity. The reliability of the scale, Cronbach's alpha coefficient was .92 and the factor’s ranged from .77 to .87. Conclusions Eating traits scale developed in this study was verified by content validity, construct validity and reliability. It is expected to be useful measuring eating traits of Korean adults in clinical practice and research.

Objectives: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea. Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older.Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey. Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia. Conclusion Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.

Purpose: The purpose of this study was to develop eating traits scale for Korean adults and verify its validity and reliability. Methods: The initial items were developed based on the literature reviews. The first preliminary scale has consisted of 78 items and the second preliminary scale consisted of 50 items selected by 13 experts who were formed to evaluate the content validity. To review whether they could understand the questionnaires at their reading level, 27 sixth-grade elementary school students were asked to be involved in this study. The questionnaire was revised through the consultation of Korean language teachers, and the final preliminary scale was composed of 50 items. Data were collected from 329 adults aged 19 to 65 years to test validity and reliability of the scale The item analysis and exploratory factor analysis were applied. Results: Exploratory factor analysis showed 5 factors of 35 items. The factors (No. of items) were ‘Mood states (6)’, ‘Pursuit of health (6)’, ‘Stimulation of food (9)’, ‘Social situations (5)’, ‘Desire satisfaction (9)’. These 5 factors explained 55.04% of the total variance. Eating traits scale developed in this study was established construct validity. The reliability of the scale, Cronbach's alpha coefficient was .92 and the factor’s ranged from .77 to .87. Conclusions Eating traits scale developed in this study was verified by content validity, construct validity and reliability. It is expected to be useful measuring eating traits of Korean adults in clinical practice and research.

Objectives: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea. Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older.Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey. Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia. Conclusion Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.

Purpose: The purpose of this study was to develop eating traits scale for Korean adults and verify its validity and reliability. Methods: The initial items were developed based on the literature reviews. The first preliminary scale has consisted of 78 items and the second preliminary scale consisted of 50 items selected by 13 experts who were formed to evaluate the content validity. To review whether they could understand the questionnaires at their reading level, 27 sixth-grade elementary school students were asked to be involved in this study. The questionnaire was revised through the consultation of Korean language teachers, and the final preliminary scale was composed of 50 items. Data were collected from 329 adults aged 19 to 65 years to test validity and reliability of the scale The item analysis and exploratory factor analysis were applied. Results: Exploratory factor analysis showed 5 factors of 35 items. The factors (No. of items) were ‘Mood states (6)’, ‘Pursuit of health (6)’, ‘Stimulation of food (9)’, ‘Social situations (5)’, ‘Desire satisfaction (9)’. These 5 factors explained 55.04% of the total variance. Eating traits scale developed in this study was established construct validity. The reliability of the scale, Cronbach's alpha coefficient was .92 and the factor’s ranged from .77 to .87. Conclusions Eating traits scale developed in this study was verified by content validity, construct validity and reliability. It is expected to be useful measuring eating traits of Korean adults in clinical practice and research.

Objectives: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea. Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older.Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey. Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia. Conclusion Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.

Purpose: The purpose of this study was to develop eating traits scale for Korean adults and verify its validity and reliability. Methods: The initial items were developed based on the literature reviews. The first preliminary scale has consisted of 78 items and the second preliminary scale consisted of 50 items selected by 13 experts who were formed to evaluate the content validity. To review whether they could understand the questionnaires at their reading level, 27 sixth-grade elementary school students were asked to be involved in this study. The questionnaire was revised through the consultation of Korean language teachers, and the final preliminary scale was composed of 50 items. Data were collected from 329 adults aged 19 to 65 years to test validity and reliability of the scale The item analysis and exploratory factor analysis were applied. Results: Exploratory factor analysis showed 5 factors of 35 items. The factors (No. of items) were ‘Mood states (6)’, ‘Pursuit of health (6)’, ‘Stimulation of food (9)’, ‘Social situations (5)’, ‘Desire satisfaction (9)’. These 5 factors explained 55.04% of the total variance. Eating traits scale developed in this study was established construct validity. The reliability of the scale, Cronbach's alpha coefficient was .92 and the factor’s ranged from .77 to .87. Conclusions Eating traits scale developed in this study was verified by content validity, construct validity and reliability. It is expected to be useful measuring eating traits of Korean adults in clinical practice and research.